PCOS Has a New Name: What PMOS Means for You
Well, ladies, it finally happened. For years, half of us have had to explain, "No, I don't actually have a bunch of cysts on my ovaries." And now PCOS has a new name.
As of May 2026, polycystic ovary syndrome is officially polyendocrine metabolic ovarian syndrome, or PMOS (1).
TBH, when I first saw the name, I was like "THAT is what we decided to go with?! Something that sounds even more confusing?!" But the more I read about the why behind it, the more I started to like it. Let me break it down.
Why change the name at all?
Because the old one was kind of a lie. Sorry, but it was.
"Polycystic" means "many cysts." But those "cysts" aren't really cysts. They're follicles, little sacs holding eggs that never got the signal to mature and release. (If you read my What is PCOS? post, you know I've been grumbling about this for years.) Plenty of people with the condition don't have them at all, and plenty of people who do have them don't have the condition.
Meanwhile, the name said nothing about the stuff that actually runs our lives: insulin resistance, hormone chaos, higher risk of diabetes and heart disease, acne, hair growth, mood. The researchers behind the change say the old name contributed to delayed diagnosis, fragmented care, and stigma (1). Um, yes. I could have told them that at 15.
What does PMOS actually mean?
Let's take it word by word:
Polyendocrine: "Poly" means many, and "endocrine" means hormones. It involves lots of hormones, not just one. (Testosterone, insulin, LH... the gang's all here.)
Metabolic: It affects how your body handles energy, including insulin resistance and the higher risk of type 2 diabetes and heart disease.
Ovarian: The ovaries are still a big part of the story, so they kept them in.
Syndrome: A collection of symptoms that show up together, which is why no two of us look exactly alike.
So the new name describes what the condition does, instead of one ultrasound finding that half of us don't even have.
Who decided this?
This wasn't a few people in a room picking something catchy. The process was led by Professor Helena Teede at Monash University, the same team behind the international PCOS guidelines. It involved 56 academic, medical, and patient organizations and global surveys with responses from more than 14,000 people, including people with PCOS and health professionals from every region of the world (1). Patients actually got a say. That alone makes me happy.
The same paper estimates the condition affects one in eight women (1). One in eight! And most people have never heard of it under either name.
What changes for you?
Honestly? Not much, at least not right away.
Your diagnosis doesn't change. The new name is about what we call it, not how it's diagnosed. If you were diagnosed with PCOS, you have PMOS. Same condition, better name.
Your treatment doesn't change. Nothing about the rename changes what works or what your doctor should be checking.
Expect a mix of names for a while. The researchers built in a transition period (1), so you'll keep seeing "PCOS" on lab forms, insurance paperwork, and in your doctor's office for a while. Neither name is wrong right now.
What changes for this site?
You'll start seeing me write PMOS (formerly PCOS) in new posts. I'll still use "PCOS" too, because that's what most people are still searching for, and I want you to be able to find this stuff. The site is staying Success With PCOS for now.
And yes, I've been wondering: are we still cysters? Tell me in the comments!
Questions to ask your doctor
"Have you seen the new PMOS name? Will my records change?"
"Since the new name highlights the metabolic side, should we be checking my blood sugar, insulin, or cholesterol?"
"Is there anything about my care that should change, or is this just a name update?"
My Take?
While this doesn't change our day to day, it does give a more relevant framework to the disease pattern, and that allows more women to get diagnosed and get help. My hope is that this continues to bring awareness to the condition so that the NIH starts to fund much-needed research toward PCOS/PMOS. Funding has been at an appallingly low level for a condition that affects so many (2), and it's up to us to bring awareness and get this changed. Cheers to one more step toward that goal.
xx, Morgan
I'm not a doctor. I'm a patient with a biology degree who reads the research. Nothing here is medical advice.
References
(1) Teede HJ, Bahri Khomami M, Morman R, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026;407(10545):2329–2339. doi:10.1016/S0140-6736(26)00717-8
(2) Tilton AN, Ottey S, Patterson W, Azziz R. Polycystic Ovary Syndrome (PCOS)/Polyendocrine Metabolic Ovarian Syndrome (PMOS) Research Underfunding Continues. J Clin Endocrinol Metab. 2026. doi:10.1210/clinem/dgag272
